277 related articles for article (PubMed ID: 34187402)
1. Cigarette smoking may accelerate the progression of IgA nephropathy.
Wang S; Qin A; Pei G; Jiang Z; Dong L; Tan J; Tan L; Tang Y; Qin W
BMC Nephrol; 2021 Jun; 22(1):239. PubMed ID: 34187402
[TBL] [Abstract][Full Text] [Related]
2. High Neutrophil-To-Lymphocyte Ratio Is an Independent Risk Factor for End Stage Renal Diseases in IgA Nephropathy.
Wang S; Dong L; Pei G; Jiang Z; Qin A; Tan J; Tang Y; Qin W
Front Immunol; 2021; 12():700224. PubMed ID: 34456912
[TBL] [Abstract][Full Text] [Related]
3. Association of obesity with the development of end stage renal disease in IgA nephropathy patients.
Wang S; Qin A; Dong L; Tan J; Zhou X; Qin W
Front Endocrinol (Lausanne); 2023; 14():1094534. PubMed ID: 37020590
[TBL] [Abstract][Full Text] [Related]
4. Lower serum bilirubin is associated with poor renal outcome in IgA nephropathy patients.
Jiang Z; Tan J; Wang S; Dong L; Han X; Tang Y; Qin W
Int J Med Sci; 2021; 18(13):2964-2970. PubMed ID: 34220324
[No Abstract] [Full Text] [Related]
5. Positive renal familial history in IgA nephropathy is associated with worse renal outcomes: a single-center longitudinal study.
Sato Y; Tsukaguchi H; Higasa K; Kawata N; Inui K; Linh TNT; Quynh TTH; Yoshihiko I; Koiwa F; Yoshimura A
BMC Nephrol; 2021 Jun; 22(1):230. PubMed ID: 34147067
[TBL] [Abstract][Full Text] [Related]
6. Clinical and prognostic significance of C1q deposition in IgAN patients-a retrospective study.
Tian S; Yang X; Luo J; Guo H
Int Immunopharmacol; 2020 Nov; 88():106896. PubMed ID: 33182045
[TBL] [Abstract][Full Text] [Related]
7. Cigarette smoking and progression of IgA nephropathy.
Yamamoto R; Nagasawa Y; Shoji T; Iwatani H; Hamano T; Kawada N; Inoue K; Uehata T; Kaneko T; Okada N; Moriyama T; Horio M; Yamauchi A; Tsubakihara Y; Imai E; Rakugi H; Isaka Y
Am J Kidney Dis; 2010 Aug; 56(2):313-24. PubMed ID: 20471735
[TBL] [Abstract][Full Text] [Related]
8. Chronic kidney disease progression to end stage renal disease: a single center experience of the role of the underlying kidney disease.
Ekart R; Ferjuc A; Furman B; Gerjevič Š; Bevc S; Hojs R
Ther Apher Dial; 2013 Aug; 17(4):363-7. PubMed ID: 23931872
[TBL] [Abstract][Full Text] [Related]
9. A validation study of crescents in predicting ESRD in patients with IgA nephropathy.
Zhang X; Shi S; Ouyang Y; Yang M; Shi M; Pan X; Lv J; Wang Z; Ren H; Shen P; Wang W; Zhang H; Xie J; Chen N
J Transl Med; 2018 May; 16(1):115. PubMed ID: 29724226
[TBL] [Abstract][Full Text] [Related]
10. Association of high body mass index with development of interstitial fibrosis in patients with IgA nephropathy.
Wu C; Wang AY; Li G; Wang L
BMC Nephrol; 2018 Dec; 19(1):381. PubMed ID: 30594167
[TBL] [Abstract][Full Text] [Related]
11. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
Lv J; Zhang H; Zhou Y; Li G; Zou W; Wang H
Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258
[TBL] [Abstract][Full Text] [Related]
12. Glomerular C4 deposition and glomerulosclerosis predict worse renal outcomes in Chinese patients with IgA nephropathy.
Yang Y; Tang X; Yang Y; Li X; Li L; Huang K; Li Y; Li J; Fu P
Ren Fail; 2020 Nov; 42(1):629-637. PubMed ID: 32660366
[TBL] [Abstract][Full Text] [Related]
13. Measures of Urinary Protein and Albumin in the Prediction of Progression of IgA Nephropathy.
Zhao YF; Zhu L; Liu LJ; Shi SF; Lv JC; Zhang H
Clin J Am Soc Nephrol; 2016 Jun; 11(6):947-955. PubMed ID: 27026518
[TBL] [Abstract][Full Text] [Related]
14. Relationship between blood neutrophil-lymphocyte ratio and renal tubular atrophy/interstitial fibrosis in IgA nephropathy patients.
Chai L; Cai K; Wang K; Luo Q
J Clin Lab Anal; 2021 Jun; 35(6):e23774. PubMed ID: 33951240
[TBL] [Abstract][Full Text] [Related]
15. High serum IgA/C3 ratio better predicts a diagnosis of IgA nephropathy among primary glomerular nephropathy patients with proteinuria ≤ 1 g/d: an observational cross-sectional study.
Gong WY; Liu M; Luo D; Liu FN; Yin LH; Li YQ; Zhang J; Peng H
BMC Nephrol; 2019 Apr; 20(1):150. PubMed ID: 31039758
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes, when matched at presentation, do not vary between adult-onset Henöch-Schönlein purpura nephritis and IgA nephropathy.
Oh HJ; Ahn SV; Yoo DE; Kim SJ; Shin DH; Lee MJ; Kim HR; Park JT; Yoo TH; Kang SW; Choi KH; Han SH
Kidney Int; 2012 Dec; 82(12):1304-12. PubMed ID: 22895518
[TBL] [Abstract][Full Text] [Related]
17. The effect of renin-angiotensin system blockade on the incidence of end-stage renal disease in IgA nephropathy.
Tanaka S; Ninomiya T; Katafuchi R; Masutani K; Nagata M; Tsuchimoto A; Hirakata H; Kitazono T; Tsuruya K
Clin Exp Nephrol; 2016 Oct; 20(5):689-698. PubMed ID: 26564155
[TBL] [Abstract][Full Text] [Related]
18. Association of C4d deposition with clinical outcomes in IgA nephropathy.
Espinosa M; Ortega R; Sánchez M; Segarra A; Salcedo MT; González F; Camacho R; Valdivia MA; Cabrera R; López K; Pinedo F; Gutierrez E; Valera A; Leon M; Cobo MA; Rodriguez R; Ballarín J; Arce Y; García B; Muñoz MD; Praga M;
Clin J Am Soc Nephrol; 2014 May; 9(5):897-904. PubMed ID: 24578331
[TBL] [Abstract][Full Text] [Related]
19. Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population.
Le W; Liang S; Hu Y; Deng K; Bao H; Zeng C; Liu Z
Nephrol Dial Transplant; 2012 Apr; 27(4):1479-85. PubMed ID: 21965586
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome of IgA nephropathy with minimal change disease: a comparison between patients with and without minimal change disease.
Li XW; Liang SS; Le WB; Cheng SQ; Zeng CH; Wang JQ; Liu ZH
J Nephrol; 2016 Aug; 29(4):567-73. PubMed ID: 26537358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
